Dr. Vincent Ribrag studied medicine at Paris-Saclay Medical School. In 1991 he obtained his Master of Science in Molecular Biology, and in 1992 he received a Diploma of Advanced Studies in Molecular and Cellular Pharmacology from Pierre and Marie Curie University.
Dr. Ribrag holds various senior positions at Gustave Roussy, the first leading cancer-research hospital in Europe. He is currently the Head of the Hematology Department, lnterim Head of the Drug Development Department (DITEP), and the Head of its Tumor Board.
Dr. Ribrag is a member of several national and international cancer societies, including the American Society of Hematology and the French Bone Marrow Transplant Society. He is also a member of the Scientific and Administrative Committee of the GELA/Lysa study and the European Mantle Cell Lymphoma Study Group, where he is also the Associate Head of Early Trials.
Fill out the form below to book a consultation with the chosen Medical Expert.
We will contact you for further steps.